comparemela.com

Latest Breaking News On - Analyst recommendations for elevance health - Page 1 : comparemela.com

Elevance Health (NYSE:ELV) Raised to "Strong-Buy" at StockNews.com

StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a report released on Wednesday morning. A number of other analysts have also recently commented on the stock. Royal Bank of Canada increased their price target on shares of Elevance Health from $574.00 to $575.00 and […]

Massachusetts
United-states
Canada
Feliciaf-norwood
Elevance-health-stock-performance
Institutional-investors-weigh-in-on-elevance-health
News-ratings-for-elevance-health-daily
Elevance-health-company-profile
Royal-bank
Barclays
Elevance-health

Elevance Health (NYSE:ELV) Upgraded by StockNews.com to "Strong-Buy"

StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a report released on Wednesday morning. Other equities research analysts have also issued reports about the stock. Jefferies Financial Group upped their price target on shares of Elevance Health from $602.00 to $604.00 and gave the […]

Canada
United-states
Feliciaf-norwood
Elevance-health-trading
Bedel-financial-consulting-inc
Barclays
Securities-exchange-commission
Elevance-health
Hedge-funds-weigh-in-on-elevance-health
Bell-investment-advisors-inc
Royal-bank

Elevance Health (NYSE:ELV) Coverage Initiated at Robert W. Baird

Analysts at Robert W. Baird started coverage on shares of Elevance Health (NYSE:ELV – Get Free Report) in a report released on Thursday, Marketbeat reports. The firm set an “outperform” rating and a $649.00 price target on the stock. Robert W. Baird’s price target would suggest a potential upside of 20.53% from the stock’s previous […]

Canada
Alaska
United-states
Feliciaf-norwood
Robertw-baird
Hedge-funds-weigh-in-on-elevance-health
Register-financial-advisors
News-ratings-for-elevance-health-daily
Elevance-health-inc
Beaird-harris-wealth-management
Palisade-asset-management

Elevance Health (NYSE:ELV) Receives New Coverage from Analysts at Robert W. Baird

Equities research analysts at Robert W. Baird began coverage on shares of Elevance Health (NYSE:ELV – Get Free Report) in a note issued to investors on Thursday, MarketBeat reports. The brokerage set an “outperform” rating and a $649.00 price target on the stock. Robert W. Baird’s target price suggests a potential upside of 20.53% from […]

United-states
Canada
Feliciaf-norwood
Robertw-baird
Wells-fargo-company
Hedge-funds-weigh-in-on-elevance-health
Cetera-advisors
Elevance-health-company-profile
News-ratings-for-elevance-health-daily
Cetera-advisor-networks
Elevance-health-inc

Elevance Health (NYSE:ELV) Rating Increased to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a research note published on Monday morning. Other equities research analysts also recently issued reports about the company. Wells Fargo & Company increased their price target on Elevance Health from $557.00 to $600.00 and gave the […]

United-states
Canada
Feliciaf-norwood
Norges-bank
News-ratings-for-elevance-health-daily
Elevance-health
Sanders-capital
Elevance-health-company-profile
Royal-bank
Analyst-recommendations-for-elevance-health
Capital-international-investors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.